Aisner Dara L, Rumery Mathew D, Merrick Daniel T, Kondo Kimi L, Nijmeh Hala, Linderman Derek J, Doebele Robert C, Thomas Natalie, Chesnut Patrick C, Varella-Garcia Marileila, Franklin Wilbur A, Camidge D Ross
Arch Pathol Lab Med. 2016 Nov;140(11):1206-1220. doi: 10.5858/arpa.2016-0156-RA. Epub 2016 Sep 9.
Context .- In an era in which testing of patient tumor material for molecular and other ancillary studies is of increasing clinical importance for selection of therapy, the ability to test on small samplings becomes critical. Often, small samplings are rapidly depleted in the diagnostic workup or are insufficient for multiple ancillary testing approaches. Objective .- To describe technical methodologies that can be implemented to preserve and maximize tissue for molecular and other ancillary testing. Data Sources .- Retrospective analysis of a case cohort from the University of Colorado, description of techniques used at the University of Colorado, and published literature. Conclusions .- Numerous techniques can be deployed to maximize molecular and other ancillary testing, even when specimens are from small samplings. A dedicated process for molecular prioritization has a high success rate, but also increases workload, which must be factored into establishing such a process. Additionally, establishing high-fidelity communication strings is critical for success of dedicated molecular prioritization of samples. Numerous approaches can be deployed for alternative specimen types, and several technical approaches can also aid in maximizing small specimens.
背景。在一个患者肿瘤材料的分子及其他辅助研究检测对于治疗选择的临床重要性日益增加的时代,对小样本进行检测的能力变得至关重要。通常,小样本在诊断检查中会迅速耗尽,或者不足以用于多种辅助检测方法。目的。描述可用于保存并最大化用于分子及其他辅助检测的组织的技术方法。数据来源。对科罗拉多大学病例队列的回顾性分析、科罗拉多大学所使用技术的描述以及已发表的文献。结论。即使样本来自小样本,也可采用多种技术来最大化分子及其他辅助检测。专门的分子优先级排序流程成功率很高,但也会增加工作量,在建立这样一个流程时必须考虑到这一点。此外,建立高保真的沟通链条对于样本专门分子优先级排序的成功至关重要。对于替代样本类型可采用多种方法,并且几种技术方法也有助于最大化小样本。